A cost-benefit analysis of RSV prophylaxis in high risk infants.

A cost-benefit analysis of RSV prophylaxis in high risk infants. by Schrand L, Elliott J, Ross M, Bell E and Mutnick A published in Ann. Pharmacother. 2001; 35 (10): 1186-1193